Balance Sheet Aarti Drugs Limited

Equities

524348

INE767A01016

Pharmaceuticals

Market Closed - Bombay S.E. Other stock markets 03:30:48 13/03/2026 pm IST			5-day change	1st Jan Change
347.80 ^INR	-2.52%		-2.54%	-15.55%

07/03	Pinnacle Life Science Pvt. Ltd announced that it expects to receive INR 100 million in funding from Aarti Drugs Limited	CI
04/02	Aarti Drugs Limited, Q3 2026 Earnings Call, Feb 04, 2026

3cd22f9d3fdf.C77KBRJjrug0VZeFucTIJmSY3dPdS6CQalKruSh15ac.Yo6nd0ER4plnBO3Q3pv-ZzOhk7rqGdrUO2LZ4xxYhtUm-IthZiThsG0wow

Published financial data: AARTI DRUGS LIMITED

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: March	2021	2022	2023	2024	2025
Revenues	2.15TCr	2.49TCr	2.72TCr	2.53TCr	2.39TCr
Other Revenues, Total	-	-	-	-1T	-
Total Revenues	2.15TCr	2.49TCr	2.72TCr	2.53TCr	2.39TCr
Cost of Goods Sold, Total	1.33TCr	1.7TCr	1.91TCr	1.7TCr	1.56TCr
Gross Profit	822.91Cr	786.5Cr	805.81Cr	831.62Cr	825.62Cr
Selling General & Admin Expenses, Total	82Cr	84Cr	93Cr	104.73Cr	114.13Cr
Depreciation & Amortization - (IS)	50Cr	50Cr	50Cr	51Cr	56Cr
Other Operating Expenses	303.37Cr	363.84Cr	405.46Cr	410.43Cr	424.44Cr
Other Operating Expenses, Total	434.79Cr	498.11Cr	549.04Cr	566.61Cr	594.34Cr
Operating Income	388.13Cr	288.39Cr	256.77Cr	265.01Cr	231.28Cr
Interest Expense, Total	-23Cr	-21Cr	-33Cr	-34Cr	-36Cr
Interest And Investment Income	3.62Cr	2.32Cr	70.16L	2.5Cr	12Cr
Net Interest Expenses	-19Cr	-18Cr	-33Cr	-31Cr	-23Cr
Other Non Operating Income (Expenses)	-1T	1T	0	1.53Cr	3.95Cr
EBT, Excl. Unusual Items	368.79Cr	269.96Cr	224.18Cr	235.53Cr	211.77Cr
Gain (Loss) On Sale Of Investments	-	-	-	-	-
Gain (Loss) On Sale Of Assets	-	-	-	-	-
Asset Writedown	-3.04Cr	-	-	-	-
Insurance Settlements	-	-	-	-	-
Other Unusual Items	3.27Cr	-	-	-	-
EBT, Incl. Unusual Items	369.01Cr	269.96Cr	224.18Cr	235.53Cr	211.77Cr
Income Tax Expense	89Cr	65Cr	58Cr	64Cr	44Cr
Earnings From Continuing Operations	280.4Cr	205Cr	166.36Cr	171.59Cr	168.1Cr
Net Income to Company	280.4Cr	205Cr	166.36Cr	171.59Cr	168.1Cr
Minority Interest	1L	4L	-5L	-17.25L	6L
Net Income - (IS)	280.41Cr	205.04Cr	166.31Cr	171.42Cr	168.16Cr
Net Income to Common Incl Extra Items	280.41Cr	205.04Cr	166.31Cr	171.42Cr	168.16Cr
Net Income to Common Excl. Extra Items	280.41Cr	205.04Cr	166.31Cr	171.42Cr	168.16Cr
Per Share Items
Net EPS - Basic	30.09	22.14	17.96	18.65	18.42
Basic EPS - Continuing Operations	30.09	22.14	17.96	18.65	18.42
Basic Weighted Average Shares Outstanding	9.32Cr	9.26Cr	9.26Cr	9.19Cr	9.13Cr
Net EPS - Diluted	30.09	22.14	17.96	18.65	18.42
Diluted EPS - Continuing Operations	30.09	22.14	17.96	18.65	18.42
Diluted Weighted Average Shares Outstanding	9.32Cr	9.26Cr	9.26Cr	9.19Cr	9.13Cr
Normalized Basic EPS	24.73	18.23	15.13	15.99	14.51
Normalized Diluted EPS	24.73	18.23	15.13	15.99	14.51
Dividend Per Share	2.5	1	1	1	1
Payout Ratio	8.28	4.64	5.65	5.41	5.39
Supplemental Items
EBITDA	433.39Cr	335.33Cr	304.45Cr	313.99Cr	284.33Cr
EBITA	388.13Cr	288.39Cr	256.77Cr	265.01Cr	229.8Cr
EBIT	388.13Cr	288.39Cr	256.77Cr	265.01Cr	231.28Cr
EBITDAR	433.45Cr	335.39Cr	304.51Cr	314.05Cr	284.56Cr
Total Revenues (As Reported)	2.16TCr	2.5TCr	2.72TCr	2.53TCr	2.4TCr
Effective Tax Rate - (Ratio)	24.01	24.06	25.79	27.15	20.62
Total Current Taxes	93Cr	70Cr	59Cr	60Cr	52Cr
Total Deferred Taxes	-4.46Cr	-4.78Cr	-1.03Cr	4.37Cr	2.5Cr
Normalized Net Income	230.51Cr	168.76Cr	140.07Cr	147.03Cr	132.42Cr
Interest Capitalized	-	-	-	16Cr	13Cr
Interest on Long-Term Debt	17Cr	13Cr	11Cr	7.77Cr	16Cr
Non-Cash Pension Expense	91.96L	85.62L	1.03Cr	1.13Cr	1.1Cr
Supplemental Operating Expense Items
Advertising Expense	98.05L	1.35Cr	1.17Cr	2.33Cr	1.79Cr
Selling and Marketing Expenses	98.05L	1.35Cr	1.17Cr	2.33Cr	1.79Cr
Research And Development Expense From Footnotes	8.6Cr	6.61Cr	9.44Cr	12Cr	18Cr
Net Rental Expense, Total	6L	6L	6L	6L	23.6L
Imputed Operating Lease Interest Expense	3L	2L	3L	4L	15.61L
Imputed Operating Lease Depreciation	3L	4L	3L	2L	8L
Maintenance & Repair Expenses, Total	11Cr	13Cr	22Cr	19Cr	19Cr

Fiscal Period: March	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	9.78Cr	22Cr	8.96Cr	9.43Cr	7.56Cr
Short Term Investments	12Cr	12Cr	12Cr	11Cr	15Cr
Total Cash And Short Term Investments	22Cr	34Cr	21Cr	20Cr	22Cr
Accounts Receivable, Total	555.23Cr	749.9Cr	864.84Cr	704.55Cr	751.18Cr
Other Receivables	2.44Cr	69.81L	69.81L	4.72Cr	19Cr
Notes Receivable	-	-	-	23.66L	75.77L
Total Receivables	557.67Cr	750.6Cr	865.54Cr	709.51Cr	770.75Cr
Inventory	415Cr	525.94Cr	516.29Cr	485.89Cr	472.93Cr
Other Current Assets, Total	62Cr	82Cr	90Cr	105Cr	73Cr
Total Current Assets	1.06TCr	1.39TCr	1.49TCr	1.32TCr	1.34TCr
Gross Property Plant And Equipment	1.12TCr	1.25TCr	1.41TCr	1.61TCr	1.76TCr
Accumulated Depreciation	-432.25Cr	-479.06Cr	-525.96Cr	-574.6Cr	-626.77Cr
Net Property Plant And Equipment	684.4Cr	766.52Cr	885.78Cr	1.04TCr	1.13TCr
Long-term Investments	17Cr	19Cr	19Cr	20Cr	22Cr
Other Intangibles, Total	25.52L	15.33L	79.43L	37Cr	63Cr
Other Long-Term Assets, Total	7.26Cr	28Cr	24Cr	20Cr	18Cr
Total Assets	1.77TCr	2.21TCr	2.42TCr	2.43TCr	2.57TCr
Liabilities
Accounts Payable, Total	329.97Cr	468.67Cr	480.27Cr	449.61Cr	433.94Cr
Accrued Expenses, Total	17Cr	7.68Cr	9.16Cr	7.18Cr	8.6Cr
Short-term Borrowings	157.21Cr	356.34Cr	360.55Cr	214.7Cr	-
Current Portion of Long-Term Debt	40Cr	44Cr	41Cr	72Cr	328.24Cr
Current Portion of Leases	2.8Cr	2.6Cr	1.99Cr	94.96L	1.18Cr
Current Income Taxes Payable	-	-	-	1.18Cr	-
Other Current Liabilities	49Cr	61Cr	40Cr	50Cr	65Cr
Total Current Liabilities	595.36Cr	940.06Cr	932.98Cr	795.54Cr	836.97Cr
Long-Term Debt	147.56Cr	138.5Cr	204.68Cr	275.33Cr	284Cr
Long-Term Leases	3.58Cr	1.88Cr	40.31L	91.4L	1.65Cr
Unearned Revenue Non Current	16.99L	16.99L	16.99L	16.99L	16.01L
Pension & Other Post Retirement Benefits	1.82Cr	2.87Cr	3.03Cr	2.74Cr	4.32Cr
Deferred Tax Liability Non Current	77Cr	72Cr	71Cr	76Cr	78Cr
Other Non Current Liabilities	27Cr	16Cr	16Cr	-1T	-
Total Liabilities	852.61Cr	1.17TCr	1.23TCr	1.15TCr	1.21TCr
Common Stock, Total	93Cr	93Cr	93Cr	92Cr	91Cr
Additional Paid In Capital	-	-	-	-	-
Retained Earnings	801.77Cr	924.02Cr	1.08TCr	1.17TCr	1.26TCr
Comprehensive Income and Other	18Cr	20Cr	19Cr	19Cr	22Cr
Total Common Equity	913.42Cr	1.04TCr	1.19TCr	1.28TCr	1.37TCr
Minority Interest	-2L	-6L	23.33L	40.58L	34.43L
Total Equity	913.41Cr	1.04TCr	1.19TCr	1.28TCr	1.37TCr
Total Liabilities And Equity	1.77TCr	2.21TCr	2.42TCr	2.43TCr	2.57TCr
Supplemental Items
ECS Total Shares Outstanding on Filing Date	9.32Cr	9.26Cr	9.26Cr	9.19Cr	9.13Cr
ECS Total Common Shares Outstanding	9.32Cr	9.26Cr	9.26Cr	9.19Cr	9.13Cr
Book Value / Share	98.01	111.92	128.77	139.4	149.99
Tangible Book Value	913.17Cr	1.04TCr	1.19TCr	1.24TCr	1.31TCr
Tangible Book Value Per Share	97.98	111.9	128.69	135.39	143.07
Total Debt	350.76Cr	542.82Cr	608.91Cr	564.28Cr	615.07Cr
Net Debt	328.77Cr	508.43Cr	588.06Cr	543.96Cr	592.93Cr
Debt Equivalent of Unfunded Proj. Benefit Obligation	1.02Cr	2.29Cr	2.23Cr	83.51L	2.38Cr
Debt Equivalent Oper. Leases	48L	48L	48L	48L	1.89Cr
Minority Interest, Total (Incl. Fin. Div)	-2L	-6L	23.33L	40.58L	34.43L
Account Code - Inventory Valuation	5	5	5	5	5
Inventories - Raw Materials, Total	203.02Cr	227.24Cr	201.63Cr	188.47Cr	182.15Cr
Inventories - Work In Process, Total	112.42Cr	162.53Cr	172.82Cr	128.13Cr	116.79Cr
Inventories - Finished Goods, Total	89Cr	125.54Cr	126.53Cr	149.04Cr	158.56Cr
Inventories - Others	10Cr	11Cr	15Cr	20Cr	15Cr
Land - (BS)	65Cr	93Cr	94Cr	94Cr	95Cr
Buildings, Total	188.22Cr	192.07Cr	193.09Cr	225.71Cr	241.88Cr
Machinery, Total	838.29Cr	879.23Cr	912.35Cr	1.06TCr	1.15TCr
Full Time Employees	1.62T	1.45T	1T	1.06T	1.28T
Accumulated Allowance for Doubtful Accounts (Supple)	3.49Cr	4.28Cr	3.96Cr	2.97Cr	5.59Cr

Fiscal Period: March	2021	2022	2023	2024	2025
Net Income	280.41Cr	205.04Cr	166.31Cr	171.42Cr	168.16Cr
Depreciation & Amortization - CF	49Cr	50Cr	50Cr	51Cr	56Cr
Amortization of Goodwill and Intangible Assets - (CF)	-	-	-	-	-1.49Cr
Depreciation & Amortization, Total	49Cr	50Cr	50Cr	51Cr	54Cr
Amortization of Deferred Charges, Total - (CF)	1.24Cr	4L	6L	39.88L	1.58Cr
(Gain) Loss From Sale Of Asset	-3.27Cr	-2L	-11.12L	18.34L	-3L
(Gain) Loss on Sale of Investments - (CF)	-	-	-	29.17L	-27.06L
Asset Writedown & Restructuring Costs	3.04Cr	-	-	-	1.23Cr
Provision and Write-off of Bad Debts	84.66L	1.69Cr	75.94L	1.9Cr	3.72Cr
Other Operating Activities, Total	10Cr	23.03L	32Cr	31Cr	12Cr
Change In Accounts Receivable	-65Cr	-193.87Cr	-94Cr	161.07Cr	34Cr
Change In Inventories	-89Cr	-110.63Cr	5.82Cr	34Cr	13Cr
Change In Accounts Payable	-31Cr	117.15Cr	-28Cr	-93Cr	-44Cr
Cash from Operations	154.85Cr	70Cr	134.2Cr	358.92Cr	244.58Cr
Capital Expenditure	-88Cr	-151.97Cr	-164.82Cr	-226.33Cr	-177.16Cr
Sale of Property, Plant, and Equipment	11Cr	2L	14.54L	18.72L	5L
Investment in Marketable and Equity Securities, Total	-	-	-	-	27.06L
Other Investing Activities, Total	5.57Cr	3.09Cr	70.04L	2.5Cr	12Cr
Cash from Investing	-72Cr	-148.86Cr	-163.97Cr	-223.65Cr	-164.63Cr
Short Term Debt Issued, Total	-	-	1.4Cr	-	41Cr
Long-Term Debt Issued, Total	-	202.82Cr	60Cr	148.18Cr	70Cr
Total Debt Issued	-	202.82Cr	61Cr	148.18Cr	111.16Cr
Short Term Debt Repaid, Total	-	-	-	-124.53Cr	-
Long-Term Debt Repaid, Total	-35Cr	-6.87Cr	-	-46Cr	-78Cr
Total Debt Repaid	-35Cr	-6.87Cr	-	-170.47Cr	-78Cr
Issuance of Common Stock	-	-	75.56L	-	-
Repurchase of Common Stock	-	-74Cr	-	-60Cr	-73Cr
Common Dividends Paid	-23Cr	-9.51Cr	-9.4Cr	-9.27Cr	-9.06Cr
Common & Preferred Stock Dividends Paid	-23Cr	-9.51Cr	-9.4Cr	-9.27Cr	-9.06Cr
Other Financing Activities, Total	-23Cr	-21Cr	-36Cr	-45Cr	-33Cr
Cash from Financing	-81Cr	92Cr	17Cr	-136.03Cr	-82Cr
Miscellaneous Cash Flow Adjustments	-	-1T	-	-	1T
Net Change in Cash	2.04Cr	13Cr	-13Cr	-76.07L	-2.17Cr
Supplemental Items
Cash Interest Paid	23Cr	21Cr	36Cr	31Cr	33Cr
Cash Income Tax Paid (Refund)	97Cr	83Cr	60Cr	62Cr	55Cr
Levered Free Cash Flow	15Cr	-116.95Cr	-96Cr	102.76Cr	-15Cr
Unlevered Free Cash Flow	29Cr	-103.98Cr	-75Cr	123.71Cr	7.4Cr
Change In Net Working Capital	174.88Cr	182.3Cr	120.98Cr	-132.96Cr	16Cr
Net Debt Issued / Repaid	-35Cr	195.95Cr	61Cr	-22Cr	34Cr

Fiscal Period: March	2021	2022	2023	2024	2025
Profitability
Return on Assets	14.51	9.07	6.93	6.82	5.77
Return on Total Capital	21.05	12.68	9.49	9.08	7.55
Return On Equity %	35.81	21.03	14.93	13.87	12.68
Return on Common Equity	35.81	21.03	14.92	13.86	12.69
Margin Analysis
Gross Profit Margin %	38.19	31.6	29.67	32.89	34.59
SG&A Margin	3.78	3.38	3.43	4.14	4.78
EBITDA Margin %	20.11	13.47	11.21	12.42	11.91
EBITA Margin %	18.01	11.59	9.45	10.48	9.63
EBIT Margin %	18.01	11.59	9.45	10.48	9.69
Income From Continuing Operations Margin %	13.01	8.24	6.12	6.79	7.04
Net Income Margin %	13.01	8.24	6.12	6.78	7.04
Net Avail. For Common Margin %	13.01	8.24	6.12	6.78	7.04
Normalized Net Income Margin	10.7	6.78	5.16	5.81	5.55
Levered Free Cash Flow Margin	0.7	-4.7	-3.53	4.06	-0.63
Unlevered Free Cash Flow Margin	1.37	-4.18	-2.76	4.89	0.31
Asset Turnover
Asset Turnover	1.29	1.25	1.17	1.04	0.95
Fixed Assets Turnover	3.22	3.43	3.29	2.67	2.2
Receivables Turnover (Average Receivables)	4.13	3.81	3.36	3.22	3.28
Inventory Turnover (Average Inventory)	3.6	3.62	3.67	3.39	3.26
Short Term Liquidity
Current Ratio	1.78	1.48	1.6	1.66	1.6
Quick Ratio	0.97	0.84	0.95	0.92	0.95
Operating Cash Flow to Current Liabilities	0.26	0.07	0.14	0.45	0.29
Days Sales Outstanding (Average Receivables)	88.41	95.71	108.5	113.58	111.3
Days Outstanding Inventory (Average Inventory)	101.45	100.89	99.57	108.08	112.07
Average Days Payable Outstanding	84.67	80.39	91.12	103.45	104.13
Cash Conversion Cycle (Average Days)	105.19	116.21	116.95	118.2	119.23
Long Term Solvency
Total Debt/Equity	38.4	52.38	51.05	44.02	44.92
Total Debt / Total Capital	27.75	34.37	33.8	30.56	31
LT Debt/Equity	16.55	13.55	17.2	21.55	20.86
Long-Term Debt / Total Capital	11.96	8.89	11.38	14.96	14.39
Total Liabilities / Total Assets	48.28	53.07	50.74	47.3	46.81
EBIT / Interest Expense	16.91	13.9	7.71	7.91	6.45
EBITDA / Interest Expense	19.03	16.31	9.22	9.43	7.96
(EBITDA - Capex) / Interest Expense	15.19	8.98	4.27	2.68	3.02
Total Debt / EBITDA	0.8	1.6	1.98	1.79	2.15
Net Debt / EBITDA	0.75	1.5	1.92	1.72	2.08
Total Debt / (EBITDA - Capex)	1.01	2.91	4.28	6.29	5.68
Net Debt / (EBITDA - Capex)	0.94	2.73	4.14	6.06	5.47
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	19.31	15.49	9.14	-6.9	-5.6
Gross Profit, 1 Yr. Growth %	33.05	-4.43	2.46	3.2	-0.72
EBITDA, 1 Yr. Growth %	68.83	-22.64	-9.21	3.69	-9.45
EBITA, 1 Yr. Growth %	81.86	-25.7	-10.96	3.81	-13.29
EBIT, 1 Yr. Growth %	81.86	-25.7	-10.96	3.81	-12.73
Earnings From Cont. Operations, 1 Yr. Growth %	98.3	-26.89	-18.85	3.15	-2.04
Net Income, 1 Yr. Growth %	98.31	-26.88	-18.89	3.07	-1.9
Normalized Net Income, 1 Yr. Growth %	103.96	-26.79	-17.01	4.97	-9.94
Diluted EPS Before Extra, 1 Yr. Growth %	98.31	-26.41	-18.89	3.82	-1.19
Accounts Receivable, 1 Yr. Growth %	13.63	35.06	15.33	-18.53	6.62
Inventory, 1 Yr. Growth %	27.53	26.73	-1.84	-5.89	-2.67
Net Property, Plant and Equip., 1 Yr. Growth %	4.56	12	15.56	20.05	9.46
Total Assets, 1 Yr. Growth %	12.02	25.02	9.67	0.45	5.85
Tangible Book Value, 1 Yr. Growth %	40.27	13.47	15	6.56	4.91
Common Equity, 1 Yr. Growth %	39.99	13.46	15.06	7.47	6.82
Cash From Operations, 1 Yr. Growth %	-38.24	-55.06	90.59	169.22	-31.86
Capital Expenditures, 1 Yr. Growth %	83.64	72.25	8.45	37.32	-21.73
Levered Free Cash Flow, 1 Yr. Growth %	-88.08	-879.36	-18.08	-228.07	-114.62
Unlevered Free Cash Flow, 1 Yr. Growth %	-80.07	-454.23	-27.88	-308.16	-94.02
Dividend Per Share, 1 Yr. Growth %	400	-60	0	0	0
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	17.49	17.38	12.27	0.8	-6.25
Gross Profit, 2 Yr. CAGR %	28.97	12.76	-1.04	2.83	1.22
EBITDA, 2 Yr. CAGR %	44.75	14.29	-16.19	-3.23	-3.1
EBITA, 2 Yr. CAGR %	52.88	16.24	-18.66	-4.14	-5.12
EBIT, 2 Yr. CAGR %	52.88	16.24	-18.66	-4.14	-4.82
Earnings From Cont. Operations, 2 Yr. CAGR %	76.75	20.41	-22.97	-8.51	0.52
Net Income, 2 Yr. CAGR %	76.76	20.42	-22.99	-8.57	0.55
Normalized Net Income, 2 Yr. CAGR %	70.24	22.2	-22.05	-6.66	-2.77
Diluted EPS Before Extra, 2 Yr. CAGR %	77.82	20.81	-22.74	-8.24	1.28
Accounts Receivable, 2 Yr. CAGR %	10.04	23.88	24.8	-3.07	-6.8
Inventory, 2 Yr. CAGR %	29.72	27.13	11.54	-3.88	-4.29
Net Property, Plant and Equip., 2 Yr. CAGR %	2.24	8.22	13.76	16.21	14.64
Total Assets, 2 Yr. CAGR %	10.15	18.34	17.09	4.96	3.12
Tangible Book Value, 2 Yr. CAGR %	29.98	26.16	14.23	9.6	5.73
Common Equity, 2 Yr. CAGR %	29.65	26.03	14.26	11.2	7.15
Cash From Operations, 2 Yr. CAGR %	4.03	-47.3	-6.94	125.77	35.45
Capital Expenditures, 2 Yr. CAGR %	8.93	77.95	36.68	22.04	3.68
Levered Free Cash Flow, 2 Yr. CAGR %	1.69	-3.93	152.68	-6.26	-56.73
Unlevered Free Cash Flow, 2 Yr. CAGR %	-13.74	-16.12	59.84	9.07	-64.72
Dividend Per Share, 2 Yr. CAGR %	216.23	41.42	-36.75	0	0
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	20.11	16.82	14.57	5.48	-1.38
Gross Profit, 3 Yr. CAGR %	21.84	16.71	9.22	0.35	1.63
EBITDA, 3 Yr. CAGR %	30.04	17.47	5.85	-10.19	-5.35
EBITA, 3 Yr. CAGR %	34.72	20.2	6.36	-11.94	-7.29
EBIT, 3 Yr. CAGR %	34.72	20.2	6.36	-11.94	-7.09
Earnings From Cont. Operations, 3 Yr. CAGR %	50.47	31.69	5.57	-15.1	-6.4
Net Income, 3 Yr. CAGR %	50.47	31.7	5.56	-15.13	-6.4
Normalized Net Income, 3 Yr. CAGR %	43.62	28.5	7.41	-13.92	-7.77
Diluted EPS Before Extra, 3 Yr. CAGR %	51.08	32.52	5.78	-14.74	-5.94
Accounts Receivable, 3 Yr. CAGR %	13.98	17.82	20.96	8.26	0.06
Inventory, 3 Yr. CAGR %	14.26	28.72	16.63	5.4	-3.48
Net Property, Plant and Equip., 3 Yr. CAGR %	3	5.4	10.61	14.79	13.92
Total Assets, 3 Yr. CAGR %	8.32	14.9	15.38	11.26	5.26
Tangible Book Value, 3 Yr. CAGR %	26.52	24.22	22.33	10.88	8.01
Common Equity, 3 Yr. CAGR %	26.11	24.01	22.26	11.95	9.72
Cash From Operations, 3 Yr. CAGR %	30.44	-21.34	-18.81	32.31	51.45
Capital Expenditures, 3 Yr. CAGR %	5.75	26.95	50.87	36.89	5.24
Levered Free Cash Flow, 3 Yr. CAGR %	-36.71	100.05	-8.9	89.9	-49.54
Unlevered Free Cash Flow, 3 Yr. CAGR %	-7.93	37.98	-20.24	61.53	-58.57
Dividend Per Share, 3 Yr. CAGR %	115.44	58.74	25.99	-26.32	0
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	13.68	15.8	16.91	10.13	5.74
Gross Profit, 5 Yr. CAGR %	17.68	13.93	12.11	10.95	5.95
EBITDA, 5 Yr. CAGR %	20.64	12.25	9.09	8.7	2.07
EBITA, 5 Yr. CAGR %	23.52	13.71	10.1	9.8	1.49
EBIT, 5 Yr. CAGR %	23.52	13.71	10.1	9.8	1.62
Earnings From Cont. Operations, 5 Yr. CAGR %	32.47	20.17	15.11	13.84	3.52
Net Income, 5 Yr. CAGR %	32.48	20.18	15.11	13.82	3.53
Normalized Net Income, 5 Yr. CAGR %	32.07	18.45	12.47	13.08	3.22
Diluted EPS Before Extra, 5 Yr. CAGR %	33.5	20.9	15.53	14.4	3.96
Accounts Receivable, 5 Yr. CAGR %	10.85	20.37	18.19	8.97	8.98
Inventory, 5 Yr. CAGR %	18.4	20.2	13.16	14.53	7.76
Net Property, Plant and Equip., 5 Yr. CAGR %	5.63	5.4	7.18	9.6	11.6
Total Assets, 5 Yr. CAGR %	9.89	13.14	11.75	10.82	10.31
Tangible Book Value, 5 Yr. CAGR %	21.12	21.33	21.45	18.15	14.94
Common Equity, 5 Yr. CAGR %	20.64	20.97	21.23	18.72	15.98
Cash From Operations, 5 Yr. CAGR %	3.04	-16.81	13.98	20.19	-0.5
Capital Expenditures, 5 Yr. CAGR %	-2.43	6.91	17.2	24.96	29.85
Levered Free Cash Flow, 5 Yr. CAGR %	-14.04	119.73	9.96	47.72	-34.72
Unlevered Free Cash Flow, 5 Yr. CAGR %	43.97	32.94	14.72	25.6	-45.06
Dividend Per Share, 5 Yr. CAGR %	8.18	31.95	31.95	31.95	14.87